Reuters: World’s largest generic drugmaker earned 60 cents per diluted share, down from 94 cents a year earlier; says on track to cut $3 billion in costs by the end 2019

Reductions will come across all business units and regions; the firm plans to invest in innovation for its key products and expand sales efforts in key markets

If you’re considering doing business with an Israeli company or starting an organization there, it’s essential to know how things work there

US online retail giant reaches out to some local retailers, offering a new local Amazon platform to sell their products via delivery program in Israel